KRT9 Antikörper (AA 429-456)
Kurzübersicht für KRT9 Antikörper (AA 429-456) (ABIN2792956)
Target
Alle KRT9 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 429-456
-
Verwendungszweck
- Rabbit Anti-Human KRT9 (Center K444) Antibody
-
Immunogen
- This KRT9 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 429-456 amino acids from the Central region of human KRT9.
-
Isotyp
- Ig Fraction
-
-
-
-
Applikationshinweise
-
Western Blot, Immunohistochemistry
Recommended Dilutions
WB: 1:1000, IHC: 1:50-100Western blot analysis of KRT9 antibody (Center K444) , which was peroxidase-conjugated to the secondary antibody, followed by DAB staining. This data demonstrates the use of this antibody for immunohistochemistry, clinical relevance has not been evaluated. -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 2.0 mg/mL
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- 2-8°C (short-term), -20°C (long-term)
-
-
- KRT9 (Keratin 9 (KRT9))
-
Andere Bezeichnung
- KRT9
-
Hintergrund
-
Target Description: KRT9 is the type I keratin 9, an intermediate filament chain expressed only in the terminally differentiated epidermis of palms and soles. Mutations in this protein cause epidermolytic palmoplantar keratoderma.
Gene Symbol: KRT9
-
Molekulargewicht
- 62064 Da
-
Gen-ID
- 3857
-
UniProt
- P35527
Target
-